These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 23369225

  • 1. Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy.
    Lee TI, Kao YH, Chen YC, Huang JH, Hsiao FC, Chen YJ.
    Diabetes Res Clin Pract; 2013 Jun; 100(3):330-9. PubMed ID: 23369225
    [Abstract] [Full Text] [Related]

  • 2. PPARs modulate cardiac metabolism and mitochondrial function in diabetes.
    Lee TW, Bai KJ, Lee TI, Chao TF, Kao YH, Chen YJ.
    J Biomed Sci; 2017 Jan 10; 24(1):5. PubMed ID: 28069019
    [Abstract] [Full Text] [Related]

  • 3. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X, Salvadó L, Barroso E, Vázquez-Carrera M.
    Int J Cardiol; 2013 Oct 09; 168(4):3160-72. PubMed ID: 23932046
    [Abstract] [Full Text] [Related]

  • 4. Oxidative stress and inflammation modulate peroxisome proliferator-activated receptors with regional discrepancy in diabetic heart.
    Lee TI, Kao YH, Chen YC, Pan NH, Chen YJ.
    Eur J Clin Invest; 2010 Aug 09; 40(8):692-9. PubMed ID: 20561028
    [Abstract] [Full Text] [Related]

  • 5. Cardiac metabolism, inflammation, and peroxisome proliferator-activated receptors modulated by 1,25-dihydroxyvitamin D3 in diabetic rats.
    Lee TI, Kao YH, Chen YC, Tsai WC, Chung CC, Chen YJ.
    Int J Cardiol; 2014 Sep 09; 176(1):151-7. PubMed ID: 25062566
    [Abstract] [Full Text] [Related]

  • 6. Cardiac peroxisome-proliferator-activated receptor expression in hypertension co-existing with diabetes.
    Lee TI, Kao YH, Chen YC, Pan NH, Lin YK, Chen YJ.
    Clin Sci (Lond); 2011 Oct 09; 121(7):305-12. PubMed ID: 21501116
    [Abstract] [Full Text] [Related]

  • 7. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
    Blaschke F, Takata Y, Caglayan E, Law RE, Hsueh WA.
    Arterioscler Thromb Vasc Biol; 2006 Jan 09; 26(1):28-40. PubMed ID: 16239592
    [Abstract] [Full Text] [Related]

  • 8. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.
    Liu F, Song R, Feng Y, Guo J, Chen Y, Zhang Y, Chen T, Wang Y, Huang Y, Li CY, Cao C, Zhang Y, Hu X, Xiao RP.
    Circulation; 2015 Mar 03; 131(9):795-804. PubMed ID: 25637627
    [Abstract] [Full Text] [Related]

  • 9. Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs).
    Huang TH, Roufogalis BD.
    Curr Mol Pharmacol; 2012 Jun 03; 5(2):241-7. PubMed ID: 22122453
    [Abstract] [Full Text] [Related]

  • 10. Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis.
    Lamichane S, Dahal Lamichane B, Kwon SM.
    Int J Mol Sci; 2018 Mar 22; 19(4):. PubMed ID: 29565812
    [Abstract] [Full Text] [Related]

  • 11. The selected pathophysiological aspects of PPARs activation.
    Kieć-Wilk B, Dembińska-Kieć A, Olszanecka A, Bodzioch M, Kawecka-Jaszcz K.
    J Physiol Pharmacol; 2005 Jun 22; 56(2):149-62. PubMed ID: 15985699
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome.
    Guan Y.
    J Am Soc Nephrol; 2004 Nov 22; 15(11):2801-15. PubMed ID: 15504933
    [Abstract] [Full Text] [Related]

  • 13. An overview on biological mechanisms of PPARs.
    Kota BP, Huang TH, Roufogalis BD.
    Pharmacol Res; 2005 Feb 22; 51(2):85-94. PubMed ID: 15629253
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nuclear receptors of the peroxisome proliferator-activated receptor (PPAR) family in gestational diabetes: from animal models to clinical trials.
    Arck P, Toth B, Pestka A, Jeschke U.
    Biol Reprod; 2010 Aug 01; 83(2):168-76. PubMed ID: 20427759
    [Abstract] [Full Text] [Related]

  • 17. [PPAR and diabetes].
    Terauchi Y, Kadowaki T.
    Nihon Rinsho; 2005 Apr 01; 63(4):623-9. PubMed ID: 15828230
    [Abstract] [Full Text] [Related]

  • 18. Peroxisome proliferator-activated receptors and inflammation: take it to heart.
    Smeets PJ, Planavila A, van der Vusse GJ, van Bilsen M.
    Acta Physiol (Oxf); 2007 Nov 01; 191(3):171-88. PubMed ID: 17935522
    [Abstract] [Full Text] [Related]

  • 19. PPARs and Myocardial Infarction.
    Wagner KD, Wagner N.
    Int J Mol Sci; 2020 Dec 11; 21(24):. PubMed ID: 33322384
    [Abstract] [Full Text] [Related]

  • 20. PPARs as therapeutic targets in cardiovascular disease.
    van Bilsen M, van Nieuwenhoven FA.
    Expert Opin Ther Targets; 2010 Oct 11; 14(10):1029-45. PubMed ID: 20854178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.